将 MLL 与肝癌中的 HGF-MET 信号通路相联系。
Linking MLL and the HGF-MET signaling pathway in liver cancer.
机构信息
Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
出版信息
J Clin Invest. 2013 Jul;123(7):2780-3. doi: 10.1172/JCI70235. Epub 2013 Jun 24.
Abstract
Mixed-lineage leukemia (MLL; also known as myeloid/lymphoid), the human homolog of trithorax in Drosophila, is a transcriptional coactivator that plays an essential role during early development and hematopoiesis. Furthermore, MLL is critically involved in the epigenetic regulation of cell cycle, senescence, DNA damage, and stem cell self-renewal. Chromosomal aberrations of MLL in acute leukemias are well documented, but the role of this gene in solid malignancies remains unclear. In this issue of the JCI, Takeda et al. describe a novel epigenetic link between MLL and the HGF-MET signaling pathway conferring invasive and metastatic properties to hepatocellular carcinoma cells.
摘要
混合谱系白血病（MLL；也称为髓系/淋巴系）是果蝇 trithorax 的人类同源物，是一种转录共激活因子，在早期发育和造血过程中发挥着重要作用。此外，MLL 还在细胞周期、衰老、DNA 损伤和干细胞自我更新的表观遗传调控中发挥关键作用。急性白血病中 MLL 的染色体异常已有充分记录，但该基因在实体恶性肿瘤中的作用尚不清楚。在本期 JCI 中，Takeda 等人描述了 MLL 与 HGF-MET 信号通路之间的新的表观遗传联系，该联系赋予肝癌细胞侵袭和转移特性。
相似文献
1
Linking MLL and the HGF-MET signaling pathway in liver cancer.
J Clin Invest. 2013 Jul;123(7):2780-3. doi: 10.1172/JCI70235. Epub 2013 Jun 24.
2
HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.
J Clin Invest. 2013 Jul;123(7):3154-65. doi: 10.1172/JCI65566. Epub 2013 Jun 24.
3
Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
Cancer Sci. 2021 Oct;112(10):3935-3944. doi: 10.1111/cas.15054. Epub 2021 Aug 2.
4
Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Oncogene. 2002 Mar 14;21(12):1791-9. doi: 10.1038/sj.onc.1205248.
5
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.
Mol Cell Biol. 2004 Jul;24(13):5639-49. doi: 10.1128/MCB.24.13.5639-5649.2004.
6
Frat2 mediates the oncogenic activation of Rac by MLL fusions.
Blood. 2012 Dec 6;120(24):4819-28. doi: 10.1182/blood-2012-05-432534. Epub 2012 Oct 16.
7
Therapeutic targeting of MLL.
Blood. 2009 Jun 11;113(24):6061-8. doi: 10.1182/blood-2008-12-197061. Epub 2009 Mar 16.
8
The role of menin in hematopoiesis.
Adv Exp Med Biol. 2009;668:51-7. doi: 10.1007/978-1-4419-1664-8_5.
9
Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53.
Cell Cycle. 2016;15(7):886-94. doi: 10.1080/15384101.2016.1152428.
10
Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
PLoS One. 2021 Mar 11;16(3):e0248425. doi: 10.1371/journal.pone.0248425. eCollection 2021.
引用本文的文献
1
The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer.
RSC Adv. 2018 Sep 28;8(58):33464-33472. doi: 10.1039/c8ra04509g. eCollection 2018 Sep 24.
2
The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma.
Front Cell Dev Biol. 2020 Feb 7;8:55. doi: 10.3389/fcell.2020.00055. eCollection 2020.
3
TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
Int J Biol Sci. 2020 Jan 14;16(5):739-751. doi: 10.7150/ijbs.40516. eCollection 2020.
4
Epigenetic regulation of histone H3 in the process of hepatocellular tumorigenesis.
Biosci Rep. 2019 Aug 2;39(8). doi: 10.1042/BSR20191815. Print 2019 Aug 30.
5
Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma.
Onco Targets Ther. 2017 Feb 14;10:847-857. doi: 10.2147/OTT.S113353. eCollection 2017.
6
Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing.
Oncotarget. 2016 Jan 19;7(3):2629-45. doi: 10.18632/oncotarget.6380.
7
Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.
Hepat Oncol. 2015;2(1):79-93. doi: 10.2217/hep.14.24.
8
The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models.
Cancers (Basel). 2014 Aug 19;6(3):1736-52. doi: 10.3390/cancers6031736.
9
The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
Cancers (Basel). 2014 Aug 12;6(3):1631-69. doi: 10.3390/cancers6031631.
本文引用的文献
1
HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.
J Clin Invest. 2013 Jul;123(7):3154-65. doi: 10.1172/JCI65566. Epub 2013 Jun 24.
2
Next-generation sequencing: application in liver cancer-past, present and future?
Biology (Basel). 2012 Aug 31;1(2):383-94. doi: 10.3390/biology1020383.
3
Cancer genome landscapes.
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
4
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis.
Br J Cancer. 2013 Jan 15;108(1):21-4. doi: 10.1038/bjc.2012.556. Epub 2013 Jan 3.
5
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.
Lancet Oncol. 2013 Jan;14(1):55-63. doi: 10.1016/S1470-2045(12)70490-4. Epub 2012 Nov 20.
6
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.
Nat Genet. 2012 May 27;44(7):760-4. doi: 10.1038/ng.2291.
7
The central role of the c-Met pathway in rebuilding the liver.
Gut. 2012 Aug;61(8):1105-6. doi: 10.1136/gutjnl-2012-302234. Epub 2012 Mar 2.
8
Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.
Biochim Biophys Acta. 2012 Jun;1822(6):942-51. doi: 10.1016/j.bbadis.2012.02.012. Epub 2012 Feb 22.
9
Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice.
Hepatology. 2012 Apr;55(4):1215-26. doi: 10.1002/hep.24796.
10
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
J Hepatol. 2012 Jan;56(1):267-75. doi: 10.1016/j.jhep.2011.07.007. Epub 2011 Jul 23.
Zotero 插件